Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

MIRA | Mira Pharmaceuticals Inc

Index- P/E- EPS (ttm)- Insider Own30.54% Shs Outstand14.75M Perf Week0.43%
Market Cap68.88M Forward P/E- EPS next Y- Insider Trans6.53% Shs Float10.24M Perf Month-23.94%
Income- PEG- EPS next Q- Inst Own- Short Float / Ratio0.06% / 0.05 Perf Quarter-
Sales- P/S- EPS this Y- Inst Trans- Short Interest0.01M Perf Half Y-
Book/sh0.08 P/B57.68 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh0.00 P/C3444.13 EPS next 5Y- ROE- 52W Range3.00 - 7.98 Perf YTD-37.06%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-41.48% Beta-
Dividend %- Quick Ratio0.03 Sales past 5Y0.00% Gross Margin- 52W Low55.67% ATR0.66
Employees- Current Ratio0.03 Sales Q/Q- Oper. Margin- RSI (14)42.56 Volatility7.50% 18.01%
OptionableNo Debt/Eq1.61 EPS Q/Q-2097.44% Profit Margin- Rel Volume0.05 Prev Close4.70
ShortableYes LT Debt/Eq0.04 Earnings- Payout- Avg Volume135.58K Price4.67
Recom- SMA20-1.40% SMA50-17.55% SMA200-17.55% Volume7,400 Change-0.64%
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cappy George10% OwnerAug 07Buy7.00119,048833,3362,859,318Aug 24 05:38 PM
Cappy George10% OwnerAug 02Buy7.00157,1701,100,1902,740,270Aug 04 01:42 PM